Sign In
|
Register
|
About Mill Valley
|
Contact Us
Mill Valley, CA
September 01, 2020 1:29pm
7-Day Forecast
|
Traffic
Mill Valley News
Local News
Bay Area News
Business
Technology
Real Estate
Sports
High School Sports
Mill Valley Gas Prices
Ski And Snow Reports
Financial Markets
Online Reservations
Acqua Hotel
Americas Best Value Inn And Suites Mill Valley
Holiday Inn Express Mill Valley San Francisco Area
Mill Valley Inn
Tamalpais Motel
Travelodge Mill Valley/Sausalito
Casa Madrona Hotel And Spa
Cavallo Point
The Gables Inn - Sausalito - Bed And Breakfast
Vacation Packages
Rental Cars
Flights
Mill Valley Hotels
Sausalito Hotels
San Rafael Hotels
San Francisco Hotels
Asian
Bagels
Bakery
Brazilian
Brew Pubs
Burgers
Chinese
Coffee Houses
Deli
Fast Food
Ice Cream / Frozen Yogurt
Italian
Mexican
Pizza
Sandwiches
Seafood
Sports Bars
Sushi
Tapas
Wine
Attractions
Muir Woods National Monument
Family Activities
Arts & Culture
Annual Events
Museums & Historical Places
Accommodations
Bed and Breakfast
Hotel and Motel Management
Hotels & Resorts
Vacation Rentals
Apartments
Apartment Finding & Rentals
Apartments
Senior Apartments
Art & Culture
Galleries & Dealers
Theatres
Associations, Foundations and Organizations
Business & Professional Clubs
Chambers of Commerce
Civic, Social and Fraternal
Labor Unions and Labor Organizations
Non-Profits
Professional & Trade Associations
Sales Organizations
Attractions & Entertainment
Activities
Air Tours
Biking
Comedy Clubs
Events & Festivals
Galleries
General Attractions
Golfing
Group Adventures
Horseback Riding
Movie Theatres
Parks & Preserves
Theatre
Tours
Automotive
Auto Detail
Auto Rental
Dealers - Antique & Classic
Dealers - New
Dealers - Used
Mobile Home Dealers
Motorcycles
Parts & Supplies
Repair & Service
Road Service
Tires
Towing
Window Tinting and Repair
Beauty & Fitness
Barbers
Beauty Salons
Cosmetics
Dance Clubs & Studios
Fitness Equipment & Apparel
Fitness Programs
Health Clubs & Gyms
Health Food Products & Vitamins
Health Services & Home Health
Manicures
Massage
Nutrition
Personal Trainers
Piercing & Tattoo
Plastic Surgeons
Skin Treatment
Weight Loss
Yoga
Bike, Hike, Team Building
Business & Professional Services
Appraisers
Benefit & Pensions Plans
Billing Services
Bookkeeping Service
Building Maintenance & Janitorial
Business & Labor Organizations
Business Legal Services
Chambers of Commerce
Communications Services
Computer & Audio Visual Services
Consultants
Copier & Fax Services, Equipment
Courier, Delivery & Messenger Service
Credit Check & Collection Agencies
Data Processing Service
Employment Services, Placement & Agencies
Engineer and Architect Services
Equipment & Supplies, Commercial & Industrial
Equipment Rentals
Graphic Design & Art
Human Resource Services
Industrial
Internet Services
Marketing & Advertising Services
Media Services
Notary Services
Office Furniture, Equipment & Supplies
Office Machines & Service
Office Supplies
Payroll Services
Photography
Printing & Publishing
Public Relations & Publicity
Screen Printing
Security & Investigative Services
Shipping, Packaging & Postal Services
Signs & Banners
Staffing & Support Services
Trade Shows, Expos & Conventions
Translators & Interpreters
Video Production
Contractors
Air Conditioning
Architects
Building Contractors & Consultants
Concrete
Electric
Fences and Gates
Floors & Ceilings
General Contractors
Heating, Cooling & AC
Inspectors & Surveyors
Landscaping
Painting & Wallcovering
Patio and Pool Enclosures
Plumbing
Pools, Spas & Saunas
Special Trade Contractors
Domestic Services
Child Care Services
House sitting
Housecleaning
Pet Sitting and Day Care
Education
Art Education
Colleges & Universities
Cont. Education
Elementary Schools
High Schools
Libraries
Middle Schools
Preschools & Childcare
Private & Parochial
Public
Tutoring
Employment Agencies
Financial Services
Accountants & Tax
Appraisers
Banks & Credit Unions
Bookkeeping
Check Cashing & Money Orders
Debt & Credit Counseling
Debt Help
Debt Services
Escrow Services
Financial Brokers and Dealers
Financial Consultants
Financial Planning and Services
Identity Theft Services
Investments
Loans
Mortgage Lenders
Personal
Golf
Government
City & County Government
National Government
Health and Medicine
Alternative Medicine / Acupuncture
Assisted Living & Elder Care Service
Chiropractors
Counseling
Dentistry
Eye Care
Health Care Professionals
Home Health Care
Hospitals & Clinics
Massage
Medical Doctors
Medical Equipment & Supplies
Nutrition
Physical Therapist
Physicians & Surgeons
Public Health & Safety
Social Services
Specialists - Health Care Professionals
Home & Garden
Accessories
Air Conditioning
Appliances
Building Materials & Hardware
Cabinets, Racks & Shelves
Carpets & Rugs
Cleaning Supplies & Services
Contractors
Doors, Windows & Drapery
Electric
Floor Coverings
Furniture
Garages
Glass
Handyman
Heating, Cooling & AC
Home Improvement Centers
Interior Design & Decorating
Kitchen
Lawn & Garden
Locksmiths
Lumber
Nurseries & Garden Centers
Painting & Wallcoverings
Patios & Decks
Plumbing
Pools, Spas & Saunas
Roofing & Siding
Safety & Security
Sewage & Septic Systems
Sprinklers
Tools
Insurance
Agents & Brokers
Auto
Health
Home
Life
Pets
Laser Hair Removal
Legal
Attorneys
Legal Services
Manufacturing & Industrial
Agriculture
Building Materials
Computers, Electronics & Telecommunications
Electronic Equipment
Food & Beverage
Home & Garden
Import / Export / Wholesale
Industrial Supplies & Services
Machine Shops
Plastics
Textiles & Apparel
Media
Online Publications
Print Publications
Meeting & Event Planning
Event Facilities
Meeting Planners
Party Rentals & Entertainment
Miscellaneous
Nightlife
Bars and Lounges
Dinner & Music Theatres
Events & Concerts
Live Music
Night Clubs
Outdoor Living & Spas
Personal Service
Barbers, Beauty Salons & Spas
Car Wash
Child Care
Dry Cleaning and Laundry
Shoe Repair
Tailors and Alterations
Tattoos & Body Piercing
Pets
Pet Boarding & Kennels
Pet Grooming
Pet Shops
Pet Supplies & Food - Retail
Veterinary Hospitals
Real Estate
Appraisers
Commercial
Condominiums
Developers
Mobile Home Parks
Mortgage Lenders
Property Management
Real Estate Agents and Brokers
Residential
Schools
Title Companies
Religion
Storage
Restaurants
American
Asian
Bagels
Bakery
Barbecue
Breakfast
Brew Pubs
Burgers
Chinese
Coffee Houses
Deli
Fast Food
French
Greek
Ice Cream / Frozen Yogurt
Indian
Italian
Japanese
Mexican
Pizza
Sandwiches
Seafood
Steaks, Chops
Sushi
Vegetarian
Wine Bar / Tasting Room
Shopping
Accessories
Antiques
Books
Bridal Shops
Candy Stores
Children's and Infants Clothing
Clothing
Convenience Stores
Department Stores
Electronics
Flowers
Furniture
Gas Stations
Gifts & Specialty Shops
Grocery Stores
Health Food Stores
Home Improvement
Indian Arts & Crafts - Retail
Jewelry
Men's Clothing Stores
Pharmacies
Resale Shops
Shoe Stores
Shopping Centers & Malls
Smoke Shops
Sporting Goods
Thrift Stores
Toy Stores
Videos
Women's Clothing Stores
Spas
Beauty Salons
Day Spas
Resort Spas
Sports & Recreation
Arenas and Venues
Associations & Clubs
Camping & Parks
Dance Clubs & Studios, Instruction
Docks & Marinas
Equestrian
Fitness Equipment & Apparel
Golf Courses
Hiking
Instruction
Recreation Facilities
Sporting Goods
Tennis
Technology
Communications
Computer Maintenance and Repair
Computer Services & Consultants
E-commerce
Internet Advertising & Services
Semiconductor
Software
Web Design
Web Development
Travel & Transportation
Airlines & Airports
Attractions
Auto Rentals
Bus Lines & Charters
Cruises
Hotels & Resorts
Passport Services
RV Parks and Recreational Vehicles
Taxi, Limousine & Shuttle
Tours & Excursions
Travel Agencies
Weddings
Cakes & Caterers
Ceremony & Reception Venues
Consultants & Planners
Entertainment
Florists
Your Business Here
Apartments
Real Eatate Agents
Mortgage Lenders
Relocating To Mill Valley
Classifieds
Jobs
Cars
Forums
Coupons
Archives
Contests
Search Hotels in Mill Valley
CHECK-IN:
CHECK-OUT:
ROOMS:
1
2
3
4
Find A Business
or
Browse Listings
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Sanofi-Aventis S.A. ADR
(NQ:
SNY
)
53.27
+0.39 (+0.74%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Sanofi-Aventis S.A. ADR
< Previous
1
2
3
4
5
6
7
8
9
...
28
29
Next >
FDA Panel Rejects Lexicon's Zynquista For Type 1 Diabetes
Today 9:05 EDT
Lexicon Pharmaceuticals' sotagliflozin, under review as an adjunct to insulin for type 1 diabetes and CKD, faced an FDA panel vote against approval, with mixed expert support.
Via
Benzinga
Exposures
Product Safety
Why Is Regeneron Pharmaceuticals Stock Trading Lower Today?
October 31, 2024
Regeneron reports Q3 EPS of $12.46, up 8% YoY, beating estimates. Revenue rose 11% to $3.72 billion. Key growth from Eylea, Libtayo, and Dupixent drives performance.
Via
Benzinga
Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split
October 28, 2024
One of these players has split its stock in the past. The other one hasn't.
Via
The Motley Fool
Why Sanofi Stock Flew Higher on Friday
October 25, 2024
No investor can ignore a crushing bottom-line beat and raised profitability guidance.
Via
The Motley Fool
Sanofi (SNY) Q3 2024 Earnings Call Transcript
October 25, 2024
SNY earnings call for the period ending September 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Sanofi's Earnings Outlook
October 24, 2024
Via
Benzinga
NASDAQ:SNY is probably undervalued for the fundamentals it is displaying.
October 03, 2024
SANOFI-ADR (NASDAQ:SNY) is an undervalued gem with solid fundamentals.
Via
Chartmill
Eli Lilly's Newly FDA-Approved Eczema Drug Improves Skin And Itch In Patients Previously Treated With Sanofi/Regeneron's Dupixent
October 25, 2024
Eli Lilly's Ebglyss improves skin and itch symptoms in eczema patients, including Dupixent-treated cases, with positive Phase 3b ADapt study results shared.
Via
Benzinga
Sanofi Eyes Breakout After Pharma Titan Rides Vaccine Sales To Quarterly Beat
October 25, 2024
The company also hiked its profit outlook for the year and expects single-digit growth.
Via
Investor's Business Daily
Sanofi Earns $5B Q3 Core Profit On Strong Dupixent And Vaccine Sales, Raises 2024 Forecast
October 25, 2024
Sanofi's Q3 earnings surged, with a 14.4% increase in income to €4.61 billion, led by Dupixent and new launches. Revenue beat estimates, reaching €13.44 billion, up 12.3%.
Via
Benzinga
Markets Mixed Again; DECK, SKX Beat After The Bell
October 25, 2024
Over the past week or so of trading, we’ve seen the stock market begin to snarl at current valuation levels.
Via
Talk Markets
Sanofi Engages In Exclusive Talks With US Private Equity CD&R For Its Consumer Health Business
October 21, 2024
Sanofi and private equity firm CD&R are in negotiations to sell a 50% stake in Opella, Sanofi's consumer healthcare division. With a €16B valuation, Opella is the third-largest player in the global OTC...
Via
Benzinga
This Vaccine Stock Just Dropped by 20%: Should You Buy the Dip?
October 21, 2024
Let's look beyond this piece of bad news from regulators.
Via
The Motley Fool
European Medicines Agency's Panel Supports Approval Of Novartis' Kisqali In Patients With Early-Breast Cancer
October 18, 2024
Novartis' Kisqali receives a positive recommendation from EMA's CHMP for adjuvant treatment of early breast cancer, showing a significant reduction in cancer recurrence in a Phase 3 trial. European...
Via
Benzinga
France's PAI Partners Ups Bid for Sanofi's Consumer Health Division As French Government Hints Possible Regulatory Block
October 18, 2024
Sanofi is in talks with CD&R to sell a 50% stake in its consumer healthcare unit, Opella. PAI Partners raised its bid by 200 million euros as the French government weighs the sale due to national...
Via
Benzinga
Sanofi Might Face Political Hurdles In $16B Consumer Pharma Unit Sale To US Private Equity CD&R
October 15, 2024
France considers blocking Sanofi's $16 billion consumer division sale to U.S. firm CD&R, citing concerns over healthcare sovereignty, job protection, and local production amidst growing political...
Via
Benzinga
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice
October 11, 2024
Sanofi is negotiating a potential sale of a 50% stake in its consumer health unit, Opella, to Clayton Dubilier & Rice. The deal, valued at $16.4 billion, could help Sanofi sharpen its focus on...
Via
Benzinga
Denali Therapeutics Stock Is Sliding After The Bell: Here's Why
October 10, 2024
Denali Therapeutics shares are moving lower in Thursday's after-hours session after the company announced that its Phase 2 study of oditrasertib was discontinued.
Via
Benzinga
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
October 07, 2024
Via
Benzinga
2 Artificial Intelligence Stocks That Could Deliver Explosive Gains
October 07, 2024
These two AI innovators are reshaping drug discovery and voice technology – find out why Wall Street sees major upside ahead.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
GSK, Sanofi, And CSL Secure US Government Fund To Boost Bird Flu Vaccine Production: Report
October 04, 2024
The U.S. government collaborates with GSK, Sanofi, and CSL to enhance bird flu vaccine production. This initiative aims to increase vaccine readiness to 10 million doses by early 2025 amid rising H5...
Via
Benzinga
Sanofi Sells Global Rights To Rare Autoimmume Drug Enjaymo For $825M Upfront To Italian Firm Recordati
October 04, 2024
Recordati will acquire global rights to Enjaymo from Sanofi for $825M, boosting its rare disease portfolio. The deal includes milestone payments and is expected to close by the end of 2024.
Via
Benzinga
Novo Nordisk/AstraZeneca's Manufacturing Partner Thermo Fisher Questioned Over Manufacturing Lapses
October 04, 2024
Thermo Fisher's Greenville facility, one of the largest in the U.S., has faced repeated FDA regulatory violations. Key concerns include contamination prevention and inadequate equipment sterilization...
Via
Benzinga
Exposures
Product Safety
US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could be Next
October 01, 2024
HHS announced lower costs for 54 Medicare Part B drugs starting in October 2024, part of the Inflation Reduction Act's rebate program, which aims to curb rising drug prices and reduce out-of-pocket...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Week In Review: Zenas Raises $259 Million In IPO
September 28, 2024
It was a quiet week for biotech news in the Chinese market. Here is a brief overview of the notable events that occurred during this time. Zenas BioPharma staged a rare US biopharma IPO worth $259...
Via
Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
FDA Approves Regeneron/Sanofi's Blockbuster Dupixent For Smoker's Lung Disease
September 27, 2024
The FDA approved Regeneron and Sanofi's Dupixent as an add-on treatment for inadequately controlled COPD, demonstrating significant reductions in exacerbations and improved lung function in Phase 3...
Via
Benzinga
Exposures
Product Safety
Regeneron And Sanofi Snag Their $6 Billion-Potential COPD Approval For Dupixent
September 27, 2024
The FDA signed off on Regeneron and Sanofi's Dupixent for patients with uncontrolled COPD.
Via
Investor's Business Daily
Exposures
Product Safety
Amgen's Rocatinlimab Has Commercial Potential Despite Competitive Landscape, Says Goldman Sachs
September 25, 2024
Amgen releases Phase 3 trial data for rocatinlimab and Uplizna, with analysts projecting strong sales despite competition in the atopic dermatitis and myasthenia gravis markets. Attention shifts to...
Via
Benzinga
Amgen's Rocatinlimab Data Beats Placebo In Atopic Dermatitis Trial, But Analyst Says Data Raises Concerns Amid Competitive Market
September 25, 2024
Amgen reports mixed results from Phase 3 trials, with rocatinlimab showing moderate success in atopic dermatitis and Uplizna outperforming expectations in myasthenia gravis, offering less frequent...
Via
Benzinga
Private Equity Firms Circle Sanofi's Consumer Health Business Amid Potential Spinoff
September 25, 2024
Sanofi plans to spin off its consumer healthcare division, which could be valued at over $16.8 billion. Private equity firms are bidding for the unit, with the spinoff expected by Q4 2024. Banks...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
28
29
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
About Us
|
Contact Us
|
Privacy Policy
|
User Agreement
|
Advertise With Us
|
Site Map
Home
|
News
|
Travel
|
Restaurants
|
Nightlife
|
Things To Do
|
Shopping
|
Calendar
|
Directory
|
Real Estate
|
Blog
|
More
Copyright © 2010-2020 MillValley.com & California Media Partners, LLC. All rights reserved.